ScholarWorks@Gyeongsang National University

Browsing by Zheng, H.Author

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 2 of 2

SCIESCOPUS
AdvanTIG-105: Phase 1b Dose-Expansion Study of Ociperlimab plus Tislelizumab in Patients with Metastatic NSCLC

Kumar, R.; Kim, S. H.; Zhong, D.; Lu, S.; Cheng, Y.; Chen, M.; Cho, E.; Clay, T.; Kang, J. -H.; Lee, G. -W., et al.

ArticleIssue Date2022CitationJournal of Thoracic Oncology, v.17, no.9, pp S375 - S376PublisherElsevier Inc.
SCIESCOPUS
Advantig-105: Phase Ib dose-expansion study of ociperlimab (OCI) plus tislelizumab (TIS) with chemotherapy (CT) in patients (pts) with metastatic oesophageal squamous cell carcinoma (ESCC) and oesophageal adenocarcinoma (EAC)

Sun, M.; Spigel, D. R.; Lee, Y-J.; Yoon, H.; Liu, Y.; Ahern, E.; Harris, S.; Lee, G-W.; Yan, D.; Chen, J., et al.

ArticleIssue Date2023CitationAnnals of Oncology, v.34, pp S862 - S863PublisherOxford University Press
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어